Found: 16
Select item for more details and to access through your institution.
Myelodysplastic Syndromes: A New Decade.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 1, doi. 10.1016/j.clml.2021.07.031
- By:
- Publication type:
- Article
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 17, doi. 10.1016/j.clml.2021.07.001
- By:
- Publication type:
- Article
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 24, doi. 10.1016/j.clml.2021.07.017
- By:
- Publication type:
- Article
On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 34, doi. 10.1016/j.clml.2021.07.027
- By:
- Publication type:
- Article
Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 44, doi. 10.1016/j.clml.2021.07.030
- By:
- Publication type:
- Article
Safety and Efficacy of a DNA Oligonucleotide Therapy in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. 52, doi. 10.1016/j.clml.2021.07.020
- By:
- Publication type:
- Article
Editorial Board.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. A1, doi. 10.1016/S2152-2650(21)02494-0
- Publication type:
- Article
Table of Contents.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. A3, doi. 10.1016/S2152-2650(21)02495-2
- Publication type:
- Article
Age, Blasts, Performance Status and Lenalidomide Therapy Influence the Outcome of Myelodysplastic Syndrome With Isolated Del(5q): A Study of 58 South American Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e1, doi. 10.1016/j.clml.2021.07.026
- By:
- Publication type:
- Article
Differential Survival Outcomes Between De Novo and Secondary Acute Promyelocytic Leukemia: An Updated Population-based study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e7, doi. 10.1016/j.clml.2021.07.023
- By:
- Publication type:
- Article
The Effects of Exercise Prescription on Aerobic Performance and Quality of Life During the Course of Lymphoma Chemotherapy: Results of a Prospective Controlled Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e15, doi. 10.1016/j.clml.2021.07.018
- By:
- Publication type:
- Article
Efficacy and Safety of Regimens Used for the Treatment of POEMS Syndrome- A Systematic Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e26, doi. 10.1016/j.clml.2021.07.033
- By:
- Publication type:
- Article
Minimal Residual Disease in Multiple Myeloma: Potential for Blood-Based Methods to Monitor Disease.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e34, doi. 10.1016/j.clml.2021.07.032
- By:
- Publication type:
- Article
Management of Myeloma Manifestations and Complications: The Cornerstone of Supportive Care: Recommendation of the Canadian Myeloma Research Group (formerly Myeloma Canada Research Network) Consensus Guideline Consortium.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e41, doi. 10.1016/j.clml.2021.07.028
- By:
- Publication type:
- Article
An Assessment of Race as a Risk Factor for Doxorubicin-Related Cardiotoxicity in Diffuse Large B-Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e57, doi. 10.1016/j.clml.2021.07.035
- By:
- Publication type:
- Article
Perceptions of Role in Treatment Decision Making and Understanding of Late Effects Among Hodgkin Lymphoma Survivors: Results From a National Survey HL Decision Making and Late Effects.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 1, p. e65, doi. 10.1016/j.clml.2021.07.034
- By:
- Publication type:
- Article